Protalix BioTherapeutics (PLX) Reports Q2 Loss of $0.05

Go back to Protalix BioTherapeutics (PLX) Reports Q2 Loss of $0.05
PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) Delayed: 2.22 -0.14 (5.93%)
Previous Close $2.36    52 Week High $1.11 
Open $2.36    52 Week Low $0.41 
Day High $2.36    P/E N/A 
Day Low $2.17    EPS $-0.29 
Volume 995,501